*  US6415048B1 - Compositional analysis system - Google Patents
Derivatives of norbornanes having hydrocarbon side chains and perfume compositions containing the same ... Derivatives of norbornanes having hydrocarbon side chains and perfume compositions containing the same ...
*  Uncategorized - Page 2 - Chemical Communications Blog
... an interesting structure where two norbornanes share a pair of neighbouring edges so it looks like three interlaced norbornanes ...
*  WO2010002674A1 - Opthalmic lens mold compounded with siloxane wax - Google Patents
... and norbornanes. It is preferred that the at least two alicyclic polymers be polymerized by ring opening metathesis followed by ...
*  2-Norbornyl cation - Wikipedia
It was also observed that the 2-exo- substituted norbornanes reacted 350 times faster than the corresponding endo- isomers. ...
Examples of "fused ring systems" are naphthalenes, indoles, quinolines, chromenes, norbornanes, and the like. [0115] The term " ...
*  List of MeSH codes (D02) - Wikipedia
... norbornanes MeSH D02.455.849.575.781.234 --- bornanes MeSH D02.455.849.575.781.234.326 --- camphor MeSH D02.455.849.575.781.500 ...
*  Magnetic inequivalence - Wikipedia
Symmetrical norbornanes and similarly rigid compounds (e.g. 7-oxabicyclo[2.2.1]heptane) also show complex signals for the ...
*  Blinatumomab - DrugBank
Blinatumomab is a BiTE-class (bi-specific T-cell engagers) constructed monoclonal antibody indicated for the treatment of Philadelphia chromosome-negative relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). Blinatumomab is manufactured by Amgen Inc. and marketed under the brand Blincyto™. A full treatment regimen consisting of two cycles of four weeks each, is priced at $178 000 USD. Blinatumomab was approved in December 2014 under the FDA's accelerated approval program, which allows approval of a drug to treat a serious or life-threatening disease based on clinical data showing the drug has an effect on a surrogate endpoint reasonably likely to predict clinical benefit to patients.
*  3-diazobornane-2-one Summary Report | CureHunter
3-diazobornane-2-one: RN & N1 from CA Vol 91 Form Index; RN given refers to (1R)-isomer; structure in first source; cpd not in Chemline 7/19/83
*  Maisto's Paste Summary Report | CureHunter
Maisto's Paste: a slowly resorbable root filling paste; composed of zinc oxide 14g, iodoform 42g, thymol 2g, camphorated chlorophenol 3cc, and anhydrous lanolin 0.5g
*  terephthalylidene dicamphor sulfonic acid - Ecamsule Summary Report | CureHunter
terephthalylidene dicamphor sulfonic acid: structure given in first source; abreviated as TDSA; FDA approved 2006 as component of Anthelios SX along with avobenzone and octocrylene
*  Shane Hickey Home Page, University of South Australia
Synthesis and evaluation of cationic norbornanes as peptidomimetic antibacterial agents', Organic and biomolecular chemistry, ...